Effectiveness and Safety of Nivolumab in the Treatment of Lung Cancer Patients in France: Preliminary Results From the Real-World EVIDENS Study
OncoImmunology - United States
doi 10.1080/2162402x.2020.1744898
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Informa UK Limited